BB Good human data, but mixed outcomes or surrogate markers. How we grade →Meta-analysis · 20 placebo-controlled trials, 1,761 people
Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials
JV Zhao, X Huang, J Zhang, et al. The Journal of Nutrition. 2023.
Bottom line: Across 20 placebo-controlled trials, berberine modestly lowered fasting glucose, HbA1c and insulin resistance, with possibly larger effects in people with diabetes, Asian participants and women.
- In plain language
- This meta-analysis pooled 20 placebo-controlled randomized trials with 1,761 participants to look at berberine and blood sugar. Compared with placebo, berberine lowered fasting glucose by 0.52 mmol/L, HbA1c by 4.48 mmol/mol (about 0.4 percentage points), fasting insulin by 2.36 mU/L and HOMA-IR, a measure of insulin resistance, by 0.85. Fasting glucose fell more in people with diabetes and in Asian participants. Drops in fasting glucose and HOMA-IR may also have been larger in women than in men.
- Limits
- Only 7 trials (756 people) reported HbA1c. The comparison between sexes rests on 4 trials in women and 1 in men. The authors say the subgroup results need to be replicated.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Berberine and glucose metabolism
- BB Good human data, but mixed outcomes or surrogate markers. How we grade →Graded claim: Berberine HCl: Lower blood sugar in adults with high blood sugar or type 2 diabetes (the people trials studied)
- CC Small or few human trials. Promising, not proven. How we grade →Ratings card: Berberine HCl: Healthy glucose metabolism
- Source
- doi.org/10.1016/j.tjnut.2023.08.016 · PubMed 37598753
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. Reviewed . We sell some of what we grade.